(Q55466475)

12 July 2018

title

Young age may predict a better outcome for children with diffuse pontine glioma. (English)

1 reference

12 July 2018

author name string

Alberto Broniscer

1

1 reference

12 July 2018

Fred H Laningham

2

1 reference

12 July 2018

Robert P Sanders

3

1 reference

12 July 2018

Larry E Kun

4

1 reference

12 July 2018

David W Ellison

5

1 reference

12 July 2018

Amar Gajjar

6

1 reference

12 July 2018

language of work or name

English

0 references

publication date

1 August 2008

1 reference

12 July 2018

published in

Cancer

1 reference

12 July 2018

volume

113

1 reference

12 July 2018

issue

3

1 reference

12 July 2018

page(s)

566-572

1 reference

12 July 2018

Prognostic factors in brainstem gliomas

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

Trends in reported incidence of primary malignant brain tumors in children in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

7 January 2021

Diffuse brainstem glioma in children: critical review of clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

7 January 2021

Brainstem gliomas in children. A Children's Cancer Group review of 119 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

7 January 2021

Prognostic factors in pediatric brain-stem gliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

7 January 2021

Favorable prognosis for brainstem gliomas in neurofibromatosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

7 January 2021

Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

7 January 2021

Brainstem gliomas in adults: prognostic factors and classification.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

7 January 2021

Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

7 January 2021

Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

7 January 2021

Treatment options in childhood pontine gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

7 January 2021

Brain stem gliomas: a classification system based on magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

7 January 2021

Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

7 January 2021

Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

7 January 2021

Prognostic value of contrast-enhanced magnetic resonance imaging in brainstem gliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

7 January 2021

Prognostic criteria for experimental protocols in pediatric brainstem gliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

7 January 2021

Complete remission of a diffuse pontine glioma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

7 January 2021

Survival of infants with malignant astrocytomas. A Report from the Childrens Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

7 January 2021

Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23584

7 January 2021

Identifiers

DOI

10.1002/CNCR.23584

1 reference

12 July 2018

PubMed ID

18484645

1 reference

12 July 2018